All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Cervical Intraepithelial Neoplasia-28141822
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 28141822 A793G
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
2 28141822 C801A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
3 28141822 D76E
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
4 28141822 G41R
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
5 28141822 G63D
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
6 28141822 G63S
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
7 28141822 T20I
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
8 28141822 T74A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
9 28141822 T803C
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
10 28141822 V77A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
11 28141822 R145K
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
12 28141822 K93N
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
13 28141822 R145I
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
14 28141822 R145N
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
15 28141822 A45E
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
16 28141822 A45V
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
17 28141822 C706A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
18 28141822 C706T
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
19 28141822 Q97L
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
20 28141822 S29T
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
21 28141822 A446G
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
22 28141822 G329C
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
23 28141822 K35N
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
24 28141822 Q113R
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
25 28141822 S74T
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.